|
RAB11A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.1510000043109E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93589999586408E-08 |
| Normal-vs-Stage2 |
4.103600E-02 |
| Normal-vs-Stage3 |
5.98099999999935E-05 |
| Normal-vs-Stage4 |
2.221000E-03 |
| Stage1-vs-Stage2 |
1.380360E-01 |
| Stage1-vs-Stage3 |
4.123800E-01 |
| Stage1-vs-Stage4 |
3.059200E-01 |
| Stage2-vs-Stage3 |
4.147200E-01 |
| Stage2-vs-Stage4 |
6.745400E-01 |
| Stage3-vs-Stage4 |
7.054600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06959999968126E-07 |
| Normal-vs-AfricanAmerican |
4.594400E-04 |
| Normal-vs-Asian |
5.390000E-04 |
| Caucasian-vs-AfricanAmerican |
2.316400E-01 |
| Caucasian-vs-Asian |
8.085600E-01 |
| AfricanAmerican-vs-Asian |
2.008000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.22599999994056E-07 |
| Normal-vs-Female |
2.76399999998844E-07 |
| Male-vs-Female |
4.776000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.91570000050024E-08 |
| Normal-vs-Age(41-60Yrs) |
5.56659999983999E-07 |
| Normal-vs-Age(61-80Yrs) |
1.514480E-02 |
| Normal-vs-Age(81-100Yrs) |
1.113960E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.813200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.444110E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.628600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.645900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.802400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.669800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.786400E-01 |
| Classical-VS-Follicular |
1.322360E-01 |
| Classical-VS-Other |
4.409000E-01 |
| Classical-VS-Normal |
6.67540001053624E-09 |
| Tall-VS-Follicular |
2.396400E-01 |
| Tall-VS-Other |
4.220600E-01 |
| Tall-VS-Normal |
1.211080E-04 |
| Follicular-VS-Other |
9.390000E-01 |
| Follicular-VS-Normal |
8.262700E-03 |
| Other-VS-Normal |
1.290390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.21270000000584E-05 |
| Normal-vs-N1 |
8.284700E-03 |
| N0-vs-N1 |
7.073000E-01 |
|
|
